| Species : |
Human |
| Source : |
CHO |
| Tag : |
Non |
| Predicted N Terminal : |
Gly311 ( beta A subunit) & Gly237 ( beta C subunit) |
| Form : |
Lyophilized from a 0.2 µm filtered solution in HCl with BSA as a carrier protein. |
| Bio-activity : |
Measured by its binding ability in a functional ELISA.In a 100 µL reaction mixture containing rhActivin AC at 2 nM and rhActivin RIIB/Fc Chimera dilutions at 0.02 - 41 nM, the concentration of rhActivin RIIB/Fc Chimera that produces 50% of the optimal binding response is found to be approximately 0.8 - 4 nM. |
| Molecular Mass : |
Recombinant Human INHBA&INHBC has a calculated MW of 12.9 kDa ( beta A subunit), 12.5 kDa ( beta C subunit). In SDS-PAGE migrates as 23 kDa, reducing conditions. |
| Purity : |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution : |
Reconstitute at 100 µg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin. |